After full-text evaluation, 22 studies on the impact of rpoB, katG, and inhA gene mutations associated with MDR-TB drug-resistance patterns in Ethiopia met all eligibility criteria, however, 16 studies were excluded because they were previously reviewed, and finally only 6 articles were included in this systematic review final analysis [22–27]. The gene discussed is INHA; the disease is tuberculosis.